Appoints Head of Investor Relations
February 29 2012 - 2:02AM
RNS Non-Regulatory
TIDMIMM
Immupharma PLC
29 February 2012
FOR IMMEDIATE RELEASE 29 FEBRUARY 2012
ImmuPharma plc
Appoints Head of Investor Relations
ImmuPharma plc (AIM: IMM), the specialist drug development
company, is pleased to announce that it has appointed Lisa Baderoon
as Head of Investor Relations.
Lisa Baderoon has spent over 20 years working within the City,
the majority of that time as a Partner of Buchanan, one of the
leading City financial public relations agencies, where she helped
establish its successful healthcare franchise.
Commenting on her appointment Lisa Baderoon said:"At Buchanan I
advised ImmuPharma for over six years so I am extremely excited
that I now have the opportunity of working even more closely with
the management team on its IR strategy at one of the most exciting
and pivotal stages in its development."
Dimitri Dimitriou, Chief Executive Officer of ImmuPharma,
added:"Lisa brings a wealth of experience to ImmuPharma having
advised not only us but many other companies within the healthcare
sector. We are therefore delighted that she is now going to be part
of our team."
- Ends -
For further information please contact:
ImmuPharma plc
Dimitri Dimitriou, Chief Executive Officer Tel No: + 44 (0) 20
7152 4080
Lisa Baderoon, Head of Investor Relations Tel No: + 44 (0) 7721
413496
Buchanan Tel No: + 44 (0) 20 7466 5000
Mark Court, Jessica Fontaine
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEASAPASSAEFF
Immupharma (LSE:IMM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Sep 2023 to Sep 2024